Tarah J. Ballinger

Internal Medicine

1030 W Michigan St
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

NCCN Guidelines® Insights: Survivorship, Version 3.2026.

NCCN Guidelines® Insights: Survivorship, Version 3.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: August 17, 2026

HSR26-193: Integrating Print-to-Web Outreach into Mammography Workflows to Promote Lung Cancer Screening: A Feasibility Study.

HSR26-193: Integrating Print-to-Web Outreach into Mammography Workflows to Promote Lung Cancer Screening: A Feasibility Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

HSR26-193: Integrating Print-to-Web Outreach into Mammography Workflows to Promote Lung Cancer Screening: A Feasibility Study.

HSR26-193: Integrating Print-to-Web Outreach into Mammography Workflows to Promote Lung Cancer Screening: A Feasibility Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal: Journal of the National Cancer Institute

Published: February 28, 2026

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

Journal: Cancer

Published: January 12, 2026

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.

Journal: Cancer

Published: September 28, 2025

Purpose in life and mortality among breast cancer survivors.

Purpose in life and mortality among breast cancer survivors.

Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

Published: September 24, 2025

Use of Co-Design Approaches to Identify Barriers to Health-Promoting Behaviors among African American Breast Cancer Survivors with Comorbid Obesity.

Use of Co-Design Approaches to Identify Barriers to Health-Promoting Behaviors among African American Breast Cancer Survivors with Comorbid Obesity.

Journal: Health behavior research

Published: August 22, 2025

Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women.

Racial differences in breast cancer-specific mortality and CVD-specific mortality after breast cancer in post-menopausal women.

Journal: Cardio-oncology (London, England)

Published: August 04, 2025

NCCN Guidelines® Insights: Survivorship, Version 2.2025.

NCCN Guidelines® Insights: Survivorship, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 11, 2025

NCCN Guidelines® Insights: Survivorship, Version 2.2025.

NCCN Guidelines® Insights: Survivorship, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 11, 2025

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer.

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: March 03, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026